The study of inflammation in fear-and anxiety-based disorders has gained interest as growing literature indicates that pro-inflammatory markers can directly modulate affective …
E Roohi, N Jaafari, F Hashemian - Journal of neuroinflammation, 2021 - Springer
Many patients with major depressive disorder (MDD) are reported to have higher levels of multiple inflammatory cytokines including interleukin 6 (IL-6). Recent studies both pre …
ME Renna, MS O'Toole, PE Spaeth… - Depression and …, 2018 - Wiley Online Library
Background Anxiety is characterized by prolonged preparation for real or perceived threat. This may manifest both as psychological and physiological activation, ultimately leading to …
RA Marrie - Nature Reviews Neurology, 2017 - nature.com
Most efforts aimed at understanding the notable heterogeneity of outcomes in multiple sclerosis (MS) have focused on disease-specific factors, such as symptoms at initial …
Introduction: Previous investigations have demonstrated that major depression is associated with particular patterns of cytokine signalling. The primary aim of this study was to examine …
E Won, YK Kim - International journal of molecular sciences, 2020 - mdpi.com
Stress-induced changes in the immune system, which lead to neuroinflammation and consequent brain alterations, have been suggested as possible neurobiological substrates …
G Uzunova, S Pallanti, E Hollander - International journal of …, 2021 - Taylor & Francis
COVID-19 is associated with neuropsychiatric complications, the most frequent one being anxiety. Multiple biological and psychosocial factors contribute to anxiety in COVID-19 …
M Furtado, MA Katzman - Psychiatry research, 2015 - Elsevier
As prevalence of anxiety, posttraumatic stress, and obsessive compulsive disorders continue to rise worldwide, increasing focus has been placed on immune mediated theories …
E Beurel, EM Medina-Rodriguez, RS Jope - Pharmacological reviews, 2022 - ASPET
There is a vital need to understand mechanisms contributing to susceptibility to depression to improve treatments for the 11% of Americans who currently suffer from this debilitating …